Galen Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsGalen Pharma

Galen Pharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Daunoxome	Daunorubicin	1996-04-08	2025-2032	Leukemia , Myeloid leukemia acute , Lymphoma , Precursor cell lymphoblastic leukemia-lymphoma , Meningeal neoplasms
Synera	Lidocaine, Tetracaine	2005-06-23	2026-2035	Pain , Ventricular tachycardia , Cardiac arrhythmias , Burns , Esophageal diseases , Ventricular fibrillation , Physiological sexual dysfunction , Ventricular premature complexes , Mouth diseases , Paroxysmal tachycardia , Premature ejaculation , Sepsis , Urinary tract infections , Otitis media , Bacterial infections , Gonorrhea , Pseudomonas infections , Bacterial skin diseases , Escherichia coli infections , Pelvic infection , Soft tissue infections , Clostridium infections , Streptococcal infections , Lyme disease , Bacterial pneumonia , Staphylococcal infections , Proctocolitis , Peritonitis , Bacterial meningitis , Salmonella infections , Proteus infections , Infectious bone diseases , Acinetobacter infections , Klebsiella infections , Enteritis , Epididymitis , Chancroid , Bacteroidaceae infections , Serratia infections , Septic shock , Hypotension , Anaphylaxis , Bradycardia , Heart arrest , Open-angle glaucoma , Heart block , Airway obstruction , Bronchial spasm , Myocardial infarction , Migraine disorders , Pulmonary embolism , Postoperative complications , Thromboembolism , Cerebral infarction , Coronary thrombosis , Unstable angina , Orthostatic hypotension , Cluster headache , Postpartum hemorrhage , Xerostomia , Thrombophlebitis , Leukemia , Ulcerative colitis , Ankylosing spondylitis , Vomiting , Nausea , Sarcoidosis , Thrombocytopenic purpura idiopathic , Pulmonary tuberculosis , Mycosis fungoides , Systemic lupus erythematosus , Rheumatic diseases , Bursitis , Keratitis , Allergic rhinitis perennial , Thyroiditis , Iritis , Hypercalcemia , Brain edema , Pemphigus , Addison disease , Collagen diseases , Dermatitis herpetiformis , Acne vulgaris , Chlamydia infections , Syphilis , Borrelia infections , Gram-positive bacterial infections , Rickettsia infections , Mycoplasma infections , Protozoan infections , Psittacosis , Wounds and injuries , Gastrointestinal diseases , Pneumonia , Skin diseases , Bacterial eye infections , Urinary bladder diseases , Hepatic encephalopathy , Bacteremia , Empyema , Otitis externa , Haemophilus infections , Pseudomembranous enterocolitis , Postoperative pain

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

phenylketonurias

healthy volunteers/patients

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

healthy volunteers/patients

phenylketonurias

healthy volunteers/patients

Microcrystalline cellulose

healthy volunteers/patients

phenylketonurias

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use